Blemish Correcting

Description

This Blemish Correcting Treatment Serum contains 1.9% Salicylic Acid USP as its active ingredient, which is known for its efficacy in treating acne and blemishes. The formulation is enhanced with Aloe Vera, recognized for its soothing properties, and Niacinamide, which is known to improve skin texture and tone. The product is packaged in a net volume of 2 fluid ounces (60 ml).

Uses and Indications

This drug is indicated for the treatment of acne. It is formulated as a facial serum designed to target and alleviate the symptoms associated with acne.

Dosage and Administration

Healthcare professionals are advised to ensure that the skin is thoroughly cleansed prior to the application of the product. A thin layer should be applied once daily, with the option to gradually increase the frequency to twice daily based on the patient's tolerance. In cases where bothersome drying or peeling occurs, it is recommended to reduce the frequency of application.

For patients who will be exposed to sunlight, the use of a sunscreen is strongly advised to protect the skin. Should any irritation or sensitivity develop during the course of treatment, both the product and the sunscreen should be discontinued, and the patient should consult a healthcare provider for further evaluation and guidance.

Contraindications

Use is contraindicated in the following situations:

If the product is swallowed, immediate medical assistance should be sought or contact with a Poison Control Center is advised.

Additionally, if the patient is using other topical medications, it is recommended to discontinue use and consult a healthcare professional if increased dryness or irritation occurs.

Warnings and Precautions

For external use only. It is imperative to avoid contact with the eyes, lips, and mouth to prevent irritation or adverse reactions.

Caution is advised when using this product in conjunction with other topical medications, as this may exacerbate dryness or irritation. Should such symptoms occur, it is recommended to discontinue use and consult a healthcare professional for further evaluation.

This product should be stored out of the reach of children to prevent accidental ingestion. In the event of swallowing the product, immediate medical assistance should be sought, or contact should be made with a Poison Control Center for guidance.

Side Effects

Patients using this product should be aware that it is for external use only and must be kept away from the eyes, lips, and mouth to prevent irritation or adverse effects.

In clinical settings, participants have reported that the concurrent use of other topical medications may lead to increased dryness or irritation. In such cases, it is advised to discontinue use and consult a healthcare professional.

Additionally, it is crucial to keep this product out of the reach of children. In the event of accidental ingestion, medical assistance should be sought immediately, or contact should be made with a Poison Control Center.

Drug Interactions

The concurrent use of other topical medications with this product may lead to an increased risk of dryness or irritation at the application site. In the event that such symptoms occur, it is advised to discontinue use of the product and consult a healthcare professional for further evaluation and guidance.

Packaging & NDC

Below are the non-prescription pack sizes of Blemish Correcting (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, it is crucial to seek medical assistance or contact a Poison Control Center immediately.

Geriatric Use

There is no specific information regarding the use of Blemish Correcting Serum (salicylic acid liquid) in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this product to elderly patients, as the absence of data necessitates careful consideration of individual patient factors and potential risks. Monitoring for efficacy and adverse effects is recommended in this population, given the lack of established guidelines for geriatric use.

Pregnancy

The safety of this product during pregnancy has not been established. The use of salicylic acid during pregnancy is generally contraindicated due to potential risks to the fetus. There may be a risk of teratogenic effects associated with the use of salicylic acid in pregnant women. Therefore, pregnant women should consult a healthcare provider before using this product to discuss potential risks and benefits.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available concerning the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no information available regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of specific guidance when treating patients with renal impairment.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of data does not preclude the need for careful evaluation and monitoring based on individual patient circumstances.

Overdosage

In the event of an overdosage, immediate medical assistance is essential. Healthcare professionals are advised to seek medical help or contact a Poison Control Center if the substance is ingested.

Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment of the patient's condition is crucial. Prompt recognition of symptoms can facilitate timely intervention and management.

Management procedures should include supportive care and symptomatic treatment as necessary. Continuous monitoring of the patient's vital signs and clinical status is recommended to address any complications that may arise from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to fully evaluate the nonclinical toxicology profile.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the product out of the reach of children to prevent accidental ingestion. In the event that the product is swallowed, patients should be instructed to seek medical help or contact a Poison Control Center immediately.

Additionally, it is important for healthcare providers to inform patients that using other topical medications concurrently with this product, or immediately thereafter, may lead to increased dryness or irritation of the skin. Should patients experience such symptoms, they should be advised to discontinue use of the product and consult their doctor for further guidance.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure to protect its quality. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically, with a recommendation to apply a thin layer daily, gradually increasing to twice daily as tolerated. Clinicians should advise patients to use sunscreen when going outdoors and to discontinue use if irritation or sensitivity occurs, consulting a doctor if necessary. No further information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Blemish Correcting, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)